Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: A randomized controlled trial

Journal of Psychosomatic Research

Volumn 74, Issue 1, 2013, Pages 25-30

  Zuidersma, Marij ^a   Conradi, Henk Jan ^a,b   van Melle, Joost P ^a   Ormel, Johan ^a   de Jonge, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cardiovascular prognosis; Depression treatment; Myocardial infarction

Indexed keywords

CITALOPRAM; MIRTAZAPINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DEPRESSION; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; THORAX PAIN; TREATMENT OUTCOME;

AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIANSERIN; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; PERSONALITY INVENTORY; PSYCHOMETRICS; PSYCHOTHERAPY; RECURRENCE; RISK; SURVIVAL RATE;

EID: 84871685053     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2012.08.015     Document Type: Article

References (30)

1. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011, 33:203-216.
2. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. J Am Med Assoc 2003, 289:3106-3116.
3. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, Mitchell AJ, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. J Am Med Assoc 2008, 300:2161-2171.
4. Glassman AH, Bigger JT, Gaffney M Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009, 66:1022-1029.
5. van den Brink RH, van Melle JP, Honig A, Schene AH, Crijns HJ, Lambert FP, et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial Infarction and Depression-Intervention Trial (MIND-IT). Am Heart J 2002, 144:219-225.
6. van Melle JP, de Jonge P, Honig A, Schene AH, Kuyper AM, Crijns HJ, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007, 190:460-466.
7. Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. J Am Med Assoc 2008, 300:2379-2388.
8. Gerber Y, Koren-Morag N, Myers V, Benyamini Y, Goldbourt U, Drory Y Long-term predictors of smoking cessation in a cohort of myocardial infarction survivors: a longitudinal study. Eur J Cardiovasc Prev Rehabil 2011.
9. Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, Kiss A, et al. Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease. J Clin Psychiatry 2010.
10. Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010, 72:874-881.
11. Welin C, Lappas G, Wilhelmsen L Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 2000, 247:629-639.
12. Schoevers RA, Geerlings MI, Deeg DJ, Holwerda TJ, Jonker C, Beekman AT Depression and excess mortality: evidence for a dose response relation in community living elderly. Int J Geriatr Psychiatry 2009, 24:169-176.
13. Beck AT, Rush AJ, Shaw BF, Emery G Cognitive Therapy of Depression 1979, Guilford, New York.
14. World Health Organization Composite International Diagnostic Interview (CIDI) 1990, WHO, Geneva.
15. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research 1993, WHO.
16. Zelen M A new design for randomized clinical trials. N Engl J Med 1979, 300:1242-1245.
17. Hamilton M A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
18. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, de Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
19. Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Marcel Gosselink AT, et al. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron Artery Dis 2009, 20:415-421.
20. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. J Am Med Assoc 2009, 302:2095-2103.
21. van Melle JP, de Jonge P, Ormel J, Crijns HJ, van Veldhuisen DJ, Honig A, et al. Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J 2005, 26:2650-2656.
22. Zuidersma M., Conradi H.J., van Melle J.P., Ormel J., de Jonge P. Self-reported depressive symptoms, diagnosed clinical depression and cardiac morbidity and mortality after myocardial infarction. Int J Cardiol 2012, 10.1016/j.ijcard.2012.07.00.
23. de Jonge Honig A, van Melle JP, Schene AH, Kuyper AM, Tulner D, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007, 164:1371-1378.
24. Carney RM, Blumenthal JA, Freedland KE, Youngblood M, Veith RC, Burg MM, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004, 66:466-474.
25. Taylor CB, Youngblood ME, Catellier D, Veith RC, Carney MM, Burg MM, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005, 62:792-798.
26. Scherrer JF, Garfield LD, Lustman PJ, Hauptman PJ, Chrusciel T, Zeringue A, et al. Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med 2011, 124:318-324.
27. DiMatteo MR, Lepper HS, Croghan TW Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
28. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000, 160:1818-1823.
29. Carney RM, Freedland KE Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009, 166:410-417.
30. Scherrer JF, Chrusciel T, Garfield LD, Freedland KE, Carney RM, Hauptman PJ, et al. Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction. Br J Psychiatry 2012, 200:137-142.